About ChunLab
ChunLab is a publicly listed company based in Seoul (South Korea) founded in 2009, and was acquired by CJ CheilJedang in July 2021. It delivers advanced NGS and bioinformatics solutions for genomics, metagenomics, and transcriptomics. It operates on a B2B model. Its focus areas include Biotechnology, Genomics and Bioinformatics.
Company details
ChunLab delivers advanced ngs and bioinformatics solutions for genomics, metagenomics, and transcriptomics, focusing on providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and bioinformatics. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Seoul, South Korea
- Stage Public
- SectorsHealthcare
- Website chunlab.com
- Social X Facebook
- Acquired by CJ CheilJedang (Jul 2021)
- Investors
- Acquired byCJ CheilJedang
(Jul 2021)
Investors in ChunLab
ChunLab has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CJ CheilJedang.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CJ CheilJedang is engaged in food and bio industries. | cj.co.kr | Seoul, South Korea |
Investor details for ChunLab
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of ChunLab
ChunLab is a publicly listed company on the KRX with ticker symbol 311690 in South Korea, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date26 Dec 2019
- Listed onKRX: 311690
- Listed entityCJ Bioscience. Inc.
- Exchange sectorTechnology services
Timeline of ChunLab
3 dated milestones of ChunLab across 12 years, from founding to its latest funding, stage changes and deals.
- Founded ChunLab is founded.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by CJ CheilJedang.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Chunlab
Complete news archive for ChunLab
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ChunLab
ChunLab was founded in 2009.
ChunLab is headquartered in Seoul, South Korea.
ChunLab delivers advanced ngs and bioinformatics solutions for genomics, metagenomics, and transcriptomics, focusing on providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and bioinformatics. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Yes, ChunLab is publicly traded on KRX under the ticker symbol 311690.
ChunLab has 1 investor. Key investors include CJ CheilJedang.
Yes. ChunLab was acquired by CJ CheilJedang in July 2021.